<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01901601</url>
  </required_header>
  <id_info>
    <org_study_id>OHSU IRB#00009282</org_study_id>
    <secondary_id>R01EY018184</secondary_id>
    <nct_id>NCT01901601</nct_id>
  </id_info>
  <brief_title>LALAK for Opacities</brief_title>
  <official_title>Randomized Clinical Trial of OCT-Guided Laser-Assisted Lamellar Anterior Keratoplasty in Adults for Stromal Opacities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this protocol is to compare and develop new surgical technique of
      partial-thickness corneal transplantation for treating corneal opacity. A newly developed
      technique, &quot;dovetail&quot; laser-assisted lamellar anterior keratoplasty (LALAK), will be tested
      and compared with standard full-thickness corneal transplantation, Intralase-enabled
      keratoplasty (IEK). The new LALAK technique replaces only the front portion of the cornea and
      does not have the risks associated with conventional IEK. Additionally, optical coherence
      tomography (OCT) will be used to guide the depth of the graft and donor dissections.

      The data will be analyzed to understand whether the new technique (LALAK) can repeatedly
      achieve good visual outcomes with lower risk from the operation compared to the visual
      outcomes and risk associated with the current standard of care, IEK.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Modifying procedure.
  </why_stopped>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">August 31, 2017</completion_date>
  <primary_completion_date type="Actual">August 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BSCVA (Snellen chart)</measure>
    <time_frame>24 months</time_frame>
    <description>A primary outcome measures will be BSCVA (Snellen chart)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>intraoperative perforation rate</measure>
    <time_frame>24 months</time_frame>
    <description>A primary outcome measure will be intraoperative perforation rate.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative refractive error</measure>
    <time_frame>24 months</time_frame>
    <description>A secondary outcome measures will be postoperative refractive error</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>topographic astigmatism</measure>
    <time_frame>24 months</time_frame>
    <description>A secondary outcome measures will be topographic astigmatism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>interface clarity</measure>
    <time_frame>24 months</time_frame>
    <description>A secondary outcome measures will be interface clarity (masked OCT and confocal microscopy grading)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>endothelial cell count</measure>
    <time_frame>24 months</time_frame>
    <description>A secondary outcome measures will be endothelial cell count (specular microscopy)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>24 months</time_frame>
    <description>A secondary outcome measures will be complications (rejection, interface opacification, others).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>STROMAL OPACITIES</condition>
  <arm_group>
    <arm_group_label>LALAK</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>laser-assisted lamellar anterior keratoplasty. Optical Coherence Tomography, femtosecond laser, topical anesthesia, and Retrobulbar Block or General Anesthesia will be used.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IEK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intralase-enabled keratoplasty. Femtosecond laser and Retrobulbar Block or General Anesthesia will be used.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LALAK</intervention_name>
    <description>A &quot;dovetail&quot; shaped cut will be made on the graft using a femtosecond laser at the eye bank. The cut depth will be proportional to the central stromal thickness of the graft. This graft will be separated from stromal bed by eye bank personnel for examination of the cut surface. High-quality graft will be replaced in preservation medium and shipped to the surgeon prior to surgery.
The host cornea will receive femtosecond laser cut consisting of a shallow lamellar cut with angled side cut to match the dovetail graft in a tongue-in-groove fashion. The femtosecond laser treatments will be performed under topical anesthesia in the laser suite. The femtosecond laser is an FDA-approved device for use in this indication (corneal transplantation including lamellar keratoplasty). A protective eye shield is placed over the eye. The graft will be sutured into the host bed.</description>
    <arm_group_label>LALAK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IEK</intervention_name>
    <description>A full thickness graft will be prepared at the eye bank with zigzag side cuts prepared with a femtosecond laser. The graft is separated from the rim, replaced in the preservation medium, and shipped to the surgeon prior to the surgery.
In the laser suite, the host cornea will be cut with the femtosecond laser with zigzag side cuts leaving a 70-100 micron bridge. A protective eye shield is placed over the eye. The graft will be sutured into the host bed.</description>
    <arm_group_label>IEK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Retrobulbar Block or General Anesthesia</intervention_name>
    <arm_group_label>LALAK</arm_group_label>
    <arm_group_label>IEK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>optical coherence tomography (OCT)</intervention_name>
    <description>OCT will be used to guide the depth of the graft and donor dissections. The OCT systems to be used in this study will be the RTVue (Optovue, Inc., Fremont, CA) or the Visante (Carl Zeiss Meditec, Inc., Dublin, CA). Both are FDA-approved for the mapping of corneal thickness.</description>
    <arm_group_label>LALAK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topical Anesthesia</intervention_name>
    <arm_group_label>LALAK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>femtosecond laser</intervention_name>
    <description>The femtosecond laser system to be used in this study for host cornea preparation will be the Intralase FS system (iFS, AMO, Inc., Santa Ana, CA). The iFS is FDA-approved for corneal surgery including full thickness and lamellar keratoplasty. Eye banks use earlier versions of the Intralase system which are also FDA approved for this indication.</description>
    <arm_group_label>LALAK</arm_group_label>
    <arm_group_label>IEK</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eyes with corneal opacities that cannot be adequately or safely corrected with
             spectacles, contact lens or excimer laser surface ablation. The cornea must have
             healthy endothelium (endothelial cell density &gt; 1,500/mm2).

        Exclusion Criteria:

          1. Preoperative corneal thickness less than 400 microns.

          2. Inability to give informed consent.

          3. Corneal edema

          4. Central guttata

          5. Inability to maintain stable fixation for OCT imaging.

          6. Inability to commit to required visits to complete the study.

          7. Eyes with concurrent cataract, retinal diseases, glaucoma, or other eye conditions
             that may limit the visual outcome after surgery.

          8. Patients with severe collagen vascular diseases or ocular surface disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Winston Chamberlain, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Casey Eye Institute, Oregon Health &amp; Science University</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <link>
    <url>http://www.coollab.net</url>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2013</study_first_submitted>
  <study_first_submitted_qc>July 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2013</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>David Huang</investigator_full_name>
    <investigator_title>Winston Chamberlain, MD, PhD, Assistant Professor of Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>KERATOPLASTY</keyword>
  <keyword>STROMAL OPACITIES</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

